DOCSLIB.ORG

Integrating Experimental and Physiologically Based

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Integrating Experimental and Physiologically Based INTEGRATING EXPERIMENTAL AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING APPROACHES TO EVALUATE NEUROTOXICITY OF THE HERBICIDE ATRAZINE ACROSS THE LIFESPAN by ZHOUMENG LIN (Under the Direction of Nikolay M. Filipov) ABSTRACT Atrazine (ATR) is a widely used chlorotriazine herbicide. Available experimental evidence and computational tools are insufficient for proper assessment of ATR’s risk to human health. This dissertation project aimed to determine neurotoxicity of ATR overexposure during adulthood, development, or in vitro, and to create physiologically based pharmacokinetic (PBPK) models for ATR across the lifespan in rodents. In adult male C57BL/6 mice, short-term oral ATR exposure (5-250 mg/kg) caused dose- dependent reduced performance in a novel object recognition test (NOR), open field hypoactivity and increased swimming time in a forced swim test at higher doses; the latter effects were accompanied with altered dopamine and serotonin homeostasis in the striatum and prefrontal cortex. Low-level drinking water (DW) ATR exposure (3 mg/L) during gestation and lactation resulted in hyperactivity and decreased NOR performance in mouse dams, hyperactivity in male and female juvenile offspring, decreased swimming time in male juveniles, increased marble burying in female juveniles, and decreased NOR performance in female adults. Neurochemically, DW ATR exposure increased striatal dopamine in dams and juvenile offspring. In vitro exposure (24-48 h; 12-300 µM) to ATR or its main metabolite didealkylatrazine (DACT) affected morphological differentiation of N27 dopaminergic cells with ATR mainly targeting soma enlargement (dose-dependent effect) and DACT decreasing neurite outgrowth (high-dose effect). A PBPK model for ATR and its metabolites desethylatrazine, desisopropylatrazine and DACT was developed in adult male mice and then extrapolated to rats. This adult rodent model and recent experimental data were the foundation for a subsequent developmental PBPK model that accurately described ATR’s kinetic behavior during fetal, neonatal, pregnant and lactating stages in rats. Model simulations aligned well with experimental data, including with a new pharmacokinetic study conducted with pregnant mice orally exposed to ATR, validating the cross-species extrapolation of the gestational model. In conclusion, ATR overexposure affects multiple behavioral domains and perturbs brain dopamine and serotonin homeostasis, with some effects on the offspring being sex-specific. ATR- and/or DACT-induced neuronal differentiation disruption may contribute to the observed developmental neurotoxicity. The newly developed PBPK models can be used in brain dosimetry predictions and, together with the experimental data, may improve ATR’s risk assessment. INDEX WORDS: Atrazine, Pesticides, Toxicity, Brain, Behavior, Dopamine, Serotonin, PBPK modeling, Developmental exposure, Neuronal differentiation INTEGRATING EXPERIMENTAL AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING APPROACHES TO EVALUATE NEUROTOXICITY OF THE HERBICIDE ATRAZINE ACROSS THE LIFESPAN by ZHOUMENG LIN B.Med., Southern Medical University, China, 2009 A Dissertation Submitted to the Graduate Faculty of The University of Georgia in Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY ATHENS, GEORGIA 2013 © 2013 Zhoumeng Lin All Rights Reserved INTEGRATING EXPERIMENTAL AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING APPROACHES TO EVALUATE NEUROTOXICITY OF THE HERBICIDE ATRAZINE ACROSS THE LIFESPAN by ZHOUMENG LIN Major Professor: Nikolay M. Filipov Committee: Jia-Sheng Wang Mary Alice Smith Julie A. Coffield Xiaoqin Ye Electronic Version Approved: Maureen Grasso Dean of the Graduate School The University of Georgia December 2013 ACKNOWLEDGEMENTS Firstly, I would like to thank my advisor Dr. Nikolay M. Filipov for proper guidance, continuous support and readily-available help throughout my PhD training. I really appreciate him and will always remember what he has taught or given me, such as (1) a variety of techniques and knowledge, (2) the opportunities to receive comprehensive training in the field of toxicology by learning in vitro, in vivo, and computational techniques, (3) the ways of experimental design, scientific thinking and effective writing, (4) the opportunities to receive professional training (e.g., grant writing, public presentation, and leadership), (5) the suggestions on my career development, and (6) many others. I am also grateful for his confidence in my ability to become a successful toxicologist in the future. I enjoy the time working with him, especially during the most impressive weekly mentor meetings. To me, he is not only an excellent advisor, but also a great friend. Secondly, I would like to express my sincere gratitude to Dr. Jeffrey W. Fisher. I was fortunate to take the last course of PBPK modeling offered by Dr. Fisher before he moved to FDA. Even though he works far away from Athens and is not in my Advisory Committee, he is so nice that he keeps mentoring me various computational modeling techniques throughout my graduate study and providing me with excellent professional suggestions to help me find a job. To my respected Advisory Committee members, Dr. Jia-Sheng Wang, Dr. Mary Alice Smith, Dr. Xiaoqin Ye and Dr. Julie A. Coffield, I would like to say Thank You so much for helping me review my research proposal and dissertation, attend annual Committee Meetings, provide a number of constructive suggestions and write multiple reference letters. Special thanks iv are also given to my Society of Toxicology Mentor Match Program mentor, Dr. Joshua A. Harrill, for excellent professional advice and helping me revise my CV and Cover Letter. Additionally, I would like to give my warm appreciation to my undergraduate advisor and friend, Dr. Lang Yao in the Department of Toxicology at the Southern Medical University in Guangzhou, China, who brought me into this exciting field of Toxicology and keeps encouraging me to pursue my dream. Many thanks are given to my lab members, Dr. Celia A. Dodd, Irina I. Georgieva, and Saritha Krishna. Celia and Irina showed me many techniques and Saritha taught me a lot of oral presentation skills. I really enjoyed the time working with them. Additionally, to my good friends, Dr. Sheppard A. Martin, Dr. Shuang Li, Dr. Shuo Xiao, Fei Zhao, Rong Li, and Xia Guo, thank you for helping me a lot in my dissertation research. I sincerely appreciate the Interdisciplinary Toxicology Program, Graduate School, and Department of Physiology and Pharmacology for offering me research assistantships. My home department, the Department of Physiology and Pharmacology is really an excellent environment that allows me to focus on research. Dr. Gaylen L. Edwards, Kali King and Misty Patterson in my home department, and Dr. Brain S. Cummings, Dr. Mary Alice Smith, and Joanne Mauro in the Interdisciplinary Toxicology Program always provide me with a variety of timely assistance. Thanks are given to them. Last but not least, I would like to thank my family. My parents have been doing their best to raise, educate, support and encourage me. While I was not able to be with them most of the time during the last four years, they had never complained. Instead, they always understand, support, and encourage me. I am in particularly indebted to my wife Chunla He, who is also a PhD student at the University of Georgia. We have been studying together for nine years. She v has been constantly supporting and helping me in my research and in my life without any complaints, regardless of success or failure. Even endless thanks cannot express my gratitude. For those many other friends at the University of Georgia, thank you for helping me in my daily life. Once again, I would like sincerely thank my advisor, committee members, mentors, friends, and my family. Without your support and help, I would not have completed this dissertation project. vi TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ........................................................................................................... iv LIST OF TABLES ......................................................................................................................... xi LIST OF FIGURES ..................................................................................................................... xiii ABBREVIATIONS ................................................................................................................... xviii CHAPTER 1 INTRODUCTION .........................................................................................................1 Problem statement ....................................................................................................1 Objectives, hypotheses, and specific aims ...............................................................3 2 LITERATURE REVIEW ..............................................................................................6 Pesticides..................................................................................................................6 Atrazine ..................................................................................................................12 3 SHORT-TERM ATRAZINE EXPOSURE CAUSES BEHAVIORAL DEFICITS AND DISRUPTS MONOAMINERGIC SYSTEMS IN MALE C57BL/6 MICE ......31 Abstract ..................................................................................................................32 Introduction ............................................................................................................33
Load more

Recommended publications
  • Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death Through ROS-Mediated Akt Signaling
    cancers Article Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death through ROS-Mediated Akt Signaling Diem Thi Ngoc Huynh 1,2, Yujin Jin 1, Chang-Seon Myung 1 and Kyung-Sun Heo 1,* 1 College of Pharmacy, Chungnam National University, Daejeon 34134, Korea; [email protected] (D.T.N.H.); [email protected] (Y.J.); [email protected] (C.-S.M.) 2 Department of Pharmacy, Da Nang University of Medical Technology and Pharmacy, Da Nang 550000, Vietnam * Correspondence: [email protected]; Tel.: +82-42-821-5927 Simple Summary: Breast cancer (BC) is the most common cause of cancer-related deaths among women worldwide, and its incidence has been increasing. However, current therapeutic approaches, such as chemotherapy, radiation, and hormonal therapy, have become increasingly ineffective because of their severe adverse effects and multidrug resistance. Therefore, the discovery of new potential candidates for BC therapy is essential. Here, we investigated whether ginsenoside Rh1 exhibits anticancer effects on BC. We found that this ginsenoside effectively inhibited the growth of BC cells in both cell cultures and mice. Therefore, ginsenoside Rh1 is a promising candidate for BC treatment. Abstract: Breast cancer (BC) is the leading cause of cancer-related deaths among women worldwide. Ginsenosides exhibit anticancer activity against various cancer cells. However, the effects of gin- senoside Rh1 on BC and the underlying mechanisms remain unknown. Here, we investigated the anticancer effects of Rh1 on human BC MCF-7 and HCC1428 cells and the underlying signaling pathways. The anticancer effects of Rh1 in vitro were evaluated using sulforhodamine B (SRB), Citation: Huynh, D.T.N.; Jin, Y.; 3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), clonogenic assay, propidium Myung, C.-S.; Heo, K.-S.
    [Show full text]
  • Inhibitory Effect of Selaginellins from Selaginella
    molecules Article Inhibitory Effect of Selaginellins from Selaginella tamariscina (Beauv.) Spring against Cytochrome P450 and Uridine 50-Diphosphoglucuronosyltransferase Isoforms on Human Liver Microsomes Jae-Kyung Heo 1, Phi-Hung Nguyen 2, Won Cheol Kim 1, Nguyen Minh Phuc 1 and Kwang-Hyeon Liu 1,* 1 BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, 80 Daehakro, Bukgu, Daegu 41566, Korea; [email protected] (J.-K.H.); [email protected] (W.C.K.); [email protected] (N.M.P.) 2 Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology, 18-Hoang Quoc Viet, Cau Giay, Hanoi 122100, Vietnam; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +82-53-950-8567; Fax: +82-53-950-8557 Received: 2 August 2017; Accepted: 13 September 2017; Published: 21 September 2017 Abstract: Selaginella tamariscina (Beauv.) has been used for traditional herbal medicine for treatment of cancer, hepatitis, and diabetes in the Orient. Numerous bioactive compounds including alkaloids, flavonoids, lignans, and selaginellins have been identified in this medicinal plant. Among them, selaginellins having a quinone methide unit and an alkylphenol moiety have been known to possess anticancer, antidiabetic, and neuroprotective activity. Although there have been studies on the biological activities of selaginellins, their modulatory potential of cytochrome P450 (P450) and uridine 50-diphosphoglucuronosyltransferase (UGT) activities have not been previously evaluated. In this study, we investigated the drug interaction potential of two selaginellins on ten P450 isoforms (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 2J2 and 3A) and six UGT isoforms (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using human liver microsomes and liquid chromatography-tandem mass spectrometry.
    [Show full text]
  • Cholestatic Liver Injury Induced by Food Additives, Dietary Supplements
    Vrije Universiteit Brussel Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition Vilas-Boas, Vânia; Gijbels, Eva; Jonckheer, Joop; De Waele, Elisabeth; Vinken, Mathieu Published in: Environment International DOI: 10.1016/j.envint.2019.105422 10.1016/j.envint.2019.105422 Publication date: 2020 License: CC BY-NC-ND Document Version: Final published version Link to publication Citation for published version (APA): Vilas-Boas, V., Gijbels, E., Jonckheer, J., De Waele, E., & Vinken, M. (2020). Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Environment International, 136, [105422]. https://doi.org/10.1016/j.envint.2019.105422, https://doi.org/10.1016/j.envint.2019.105422 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Analytical Reference Standards
    Cerilliant Quality ISO GUIDE 34 ISO/IEC 17025 ISO 90 01:2 00 8 GM P/ GL P Analytical Reference Standards 2 011 Analytical Reference Standards 20 811 PALOMA DRIVE, SUITE A, ROUND ROCK, TEXAS 78665, USA 11 PHONE 800/848-7837 | 512/238-9974 | FAX 800/654-1458 | 512/238-9129 | www.cerilliant.com company overview about cerilliant Cerilliant is an ISO Guide 34 and ISO 17025 accredited company dedicated to producing and providing high quality Certified Reference Standards and Certified Spiking SolutionsTM. We serve a diverse group of customers including private and public laboratories, research institutes, instrument manufacturers and pharmaceutical concerns – organizations that require materials of the highest quality, whether they’re conducing clinical or forensic testing, environmental analysis, pharmaceutical research, or developing new testing equipment. But we do more than just conduct science on their behalf. We make science smarter. Our team of experts includes numerous PhDs and advance-degreed specialists in science, manufacturing, and quality control, all of whom have a passion for the work they do, thrive in our collaborative atmosphere which values innovative thinking, and approach each day committed to delivering products and service second to none. At Cerilliant, we believe good chemistry is more than just a process in the lab. It’s also about creating partnerships that anticipate the needs of our clients and provide the catalyst for their success. to place an order or for customer service WEBSITE: www.cerilliant.com E-MAIL: [email protected] PHONE (8 A.M.–5 P.M. CT): 800/848-7837 | 512/238-9974 FAX: 800/654-1458 | 512/238-9129 ADDRESS: 811 PALOMA DRIVE, SUITE A ROUND ROCK, TEXAS 78665, USA © 2010 Cerilliant Corporation.
    [Show full text]
  • Methyl Salicylate EC No 204-317-7 CAS No 119-36-8
    Substance Evaluation Conclusion document EC No 204-317-7 SUBSTANCE EVALUATION CONCLUSION as required by REACH Article 48 and EVALUATION REPORT for Methyl salicylate EC No 204-317-7 CAS No 119-36-8 Evaluating Member State(s): France Dated: March 2021 Substance Evaluation Conclusion document EC No 204-317-7 Evaluating Member State Competent Authority French Agency for Food, Environmental and Occupational Health Safety (ANSES) on behalf of French Ministry of Environment 14 rue Pierre et Marie Curie 94701 Maisons-Alfort cedex France Email: [email protected] Year of evaluation in CoRAP: 2015 Before concluding the substance evaluation a Decision to request further information was issued on: 10 March 2016 Further information on registered substances here: http://echa.europa.eu/web/guest/information-on-chemicals/registered-substances France Page 2 of 98 March 2021 Substance Evaluation Conclusion document EC No 204-317-7 DISCLAIMER This document has been prepared by the evaluating Member State as a part of the substance evaluation process under the REACH Regulation (EC) No 1907/2006. The information and views set out in this document are those of the author and do not necessarily reflect the position or opinion of the European Chemicals Agency or other Member States. The Agency does not guarantee the accuracy of the information included in the document. Neither the Agency nor the evaluating Member State nor any person acting on either of their behalves may be held liable for the use which may be made of the information contained therein. Statements made or information contained in the document are without prejudice to any further regulatory work that the Agency or Member States may initiate at a later stage.
    [Show full text]
  • Advances in Nutrition and Cancer Indexed in Pubmed/Medline Cancer Treatment and Research
    Cancer Treatment and Research Series Editor: Steven T. Rosen Vincenzo Zappia · Salvatore Panico Gian Luigi Russo · Alfredo Budillon Fulvio Della Ragione Editors Advances in Nutrition and Cancer Indexed in PubMed/Medline Cancer Treatment and Research Volume 159 Series Editor Steven T. Rosen, Chicago, IL, USA For further volumes: http://www.springer.com/series/5808 Vincenzo Zappia • Salvatore Panico Gian Luigi Russo • Alfredo Budillon Fulvio Della Ragione Editors Advances in Nutrition and Cancer 123 Editors Vincenzo Zappia, Gian Luigi Russo, Fulvio Della Ragione Institute of Food Sciences Department of Biochemistry National Research Council and Biophysics Avellino Second University of Naples Italy Naples Alfredo Budillon Italy Department of Experimental Oncology National Cancer Institute Salvatore Panico Naples Clinical and Experimental Medicine Italy University of Naples ‘‘Federico II’’ Naples Italy ISSN 0927-3042 ISBN 978-3-642-38006-8 ISBN 978-3-642-38007-5 (eBook) DOI 10.1007/978-3-642-38007-5 Springer Heidelberg New York Dordrecht London Library of Congress Control Number: 2013947358 Ó Springer-Verlag Berlin Heidelberg 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied spe cifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work.
    [Show full text]
  • Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
    Send Orders for Reprints to [email protected] Anti-Cancer Agents in Medicinal Chemistry, 2014, 14, 000-000 1 Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy Tereza Nehybová1, Jan Šmarda1 and Petr Beneš1,2,* 1Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic and Masaryk Memorial Cancer Institute, RECAMO, Žlutý kopec 7, 656 53 Brno, Czech Republic; 2International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's University Hospital, Brno, Czech Republic Abstract: Natural products are often used in drug development due to their ability to form unique and diverse chemical structures. Coumestans are polycyclic aromatic plant secondary metabolites containing a coumestan moiety, which consists of a benzoxole fused to a chromen-2-one to form 1-Benzoxolo[3,2-c]chromen-6-one. These natural compounds are known for large number of biological activities. Many of their biological effects can be attributed to their action as phytoestrogens and polyphenols. In the last decade, anticancer effects of these compounds have been described in vitro but there is only limited number of studies based on models in vivo. More information concerning their in vivo bioavailability, stability, metabolism, toxicity, estrogenicity, cellular targets and drug interactions is therefore needed to proceed further to clinical studies. This review focuses on coumestans exhibiting anticancer properties and summarizes mechanisms of their toxicity to cancer cells. Moreover, the possible role of coumestans in cancer prevention is discussed. Keywords: Cancer, cellular target, coumestrol, coumestan, glycyrol, psoralidin, therapy, wedelolactone. INTRODUCTION also acts as antioxidant [18, 36] and prevents bone resorption by Natural products are often used in drug development due to inhibiting differentiation and function of osteoclasts and by their ability to form unique and diverse chemical structures.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0161324 A1 Johansen Et Al
    US 2008O161324A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0161324 A1 Johansen et al. (43) Pub. Date: Jul. 3, 2008 (54) COMPOSITIONS AND METHODS FOR Publication Classification TREATMENT OF VRAL DISEASES (51) Int. Cl. (76) Inventors: Lisa M. Johansen, Belmont, MA A63/495 (2006.01) (US); Christopher M. Owens, A63L/35 (2006.01) Cambridge, MA (US); Christina CI2O I/68 (2006.01) Mawhinney, Jamaica Plain, MA A63L/404 (2006.01) (US); Todd W. Chappell, Boston, A63L/35 (2006.01) MA (US); Alexander T. Brown, A63/4965 (2006.01) Watertown, MA (US); Michael G. A6II 3L/21 (2006.01) Frank, Boston, MA (US); Ralf A6IP3L/20 (2006.01) Altmeyer, Singapore (SG) (52) U.S. Cl. ........ 514/255.03: 514/647; 435/6: 514/415; Correspondence Address: 514/460, 514/275: 514/529 CLARK & ELBNG LLP 101 FEDERAL STREET BOSTON, MA 02110 (57) ABSTRACT (21) Appl. No.: 11/900,893 The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain (22) Filed: Sep. 13, 2007 embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particu Related U.S. Application Data lar embodiments, the viral disease is viral hepatitis (e.g., (60) Provisional application No. 60/844,463, filed on Sep. hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E). 14, 2006, provisional application No. 60/874.061, Also featured are screening methods for identification of filed on Dec. 11, 2006. novel compounds that may be used to treat a viral disease.
    [Show full text]
  • The Effects of Plant Estrogens on the Female Guinea Pig and on Parabioticmice
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Spring 1965 THE EFFECTS OF PLANT ESTROGENS ON THE FEMALE GUINEA PIG AND ON PARABIOTICMICE BLAIR HENDRON CAMPBELL Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation CAMPBELL, BLAIR HENDRON, "THE EFFECTS OF PLANT ESTROGENS ON THE FEMALE GUINEA PIG AND ON PARABIOTICMICE" (1965). Doctoral Dissertations. 812. https://scholars.unh.edu/dissertation/812 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. This dissertation has been microfilmed exactly as received 66-5970 CAMPBELL, D.V.M., Blair Hendron, 1936- THE EFFECTS OF PLANT ESTROGENS ON THE FEMALE GUINEA PIG AND ON PARABIOTIC MICE. University of New Hampshire, Ph.D., 1965 P h ysiology University Microfilms, Inc., Ann Arbor, Michigan Copyright by BLAIR HENDRON CAMPBELL, D.V.M. 1966 THE EFFECTS OF PLANT ESTROGENS ON THE FEMALE GUINEA PIG AND ON PARABIOTIC MICE by BLAIR HENDRON CAMPBELL D.V.M., Cornell University, I960 A THESIS Submitted to the University of New Hampshire In Partial Fulfillment of The Requirements for the Degree of Doctor of Philosophy Graduate School Department of Zoology June, 1965 This thesis has been examined and approved. ACKNOWLEDGEMENTS In an expression of appreciation, the author wishes to acknowledge the help and guidance of the following people Dr. Paul A.
    [Show full text]
  • Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds
    C/^% Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds TechnicaLBuUetin No. 1408 îsJ ■■-1 r Agricultural Research Service UNITED STATES DEPARTMENT OF AGRICULTURE 6 Studies on the Chemical and Biological Properties of Coumestrol and Related Compounds Technical Bulletin No. 1408 Agricultural Research Service UNITED STATES DEPARTMENT OF AGRICULTURE Contents Page Page Introduction 1 Synthesis of coumestans—con. Analytical procedures 3 Synthesis from previously Biological procedures 6 formed coumestans 32 Chromatographie procedures 7 Physical properties of coumestans Qualitative procedure 8 Ultraviolet absorption spectral Quantitative procedure 9 measurements 32 Other Chromatographie pro- Proton magnetic resonance cedures 10 spectral measurements 35 Isolation 14 Mass spectral measurements 37 Isolation of coumestrol from Chromatography 41 Ladino clover 15 Coumestrol in plants 43 Large-scale processing of al- Variations as affected by cut- falfa for coumestrol 16 tings and stages of growth __ 43 Isolation of compounds closely- Variations as aifected by loca- related to coumestrol 17 tion and climatic conditions __ 46 Characterization of coumestans __ 18 Variations as aifected by varietal Coumestrol 20 and genetic differences 47 Trifoliol 20 Variations as related to disease. 48 Medicagol 24 Mechanism of biosynthesis 53 4'-0-methylcoumestrol 24 Utilization of coumestrol by the 3'-Methoxycoumestrol 24 animal 55 Lucernol 25 Metabolism 58 Sativol 25 Estrogenic potency 59 11, 12-Dimethoxy-7-hydroxy- Antifertility
    [Show full text]
  • Induction of G2/M Cell Cycle Arrest Via P38/P21waf1/Cip1- Dependent Signaling Pathway Activation by Bavachinin in Non-Small-Cell Lung Cancer Cells
    molecules Article Induction of G2/M Cell Cycle Arrest via p38/p21Waf1/Cip1- Dependent Signaling Pathway Activation by Bavachinin in Non-Small-Cell Lung Cancer Cells Jih-Tung Pai 1,†, Ming-Wei Hsu 2,†, Yann-Lii Leu 3,4 , Kuo-Ting Chang 5 and Meng-Shih Weng 2,* 1 Division of Hematology and Oncology, Tao-Yuan General Hospital, Ministry of Health and Welfare, Taoyuan City 33004, Taiwan; [email protected] 2 Department of Nutritional Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan; [email protected] 3 Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan; [email protected] 4 Tissue Bank, Chang Gung Memorial Hospital, Linkou, Taoyuan City 33342, Taiwan 5 Translational Medicine Center, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City 33004, Taiwan; [email protected] * Correspondence: [email protected] † These two authors contributed equally in this work. Abstract: Lung cancer is the most commonly diagnosed malignant cancer in the world. Non-small- cell lung cancer (NSCLC) is the major category of lung cancer. Although effective therapies have been administered, for improving the NSCLC patient’s survival, the incident rate is still high. Therefore, searching for a good strategy for preventing NSCLC is urgent. Traditional Chinese medicine (TCM) Citation: Pai, J.-T.; Hsu, M.-W.; Leu, are brilliant materials for cancer chemoprevention, because of their high biological safety and low Y.-L.; Chang, K.-T.; Weng, M.-S. cost. Bavachinin, which is an active flavanone of Proralea corylifolia L., possesses anti-inflammation, Induction of G2/M Cell Cycle Arrest anti-angiogenesis, and anti-cancer activities.
    [Show full text]
  • The Plasma Gonadotropin Profile Throughout the Estrous Cycle
    c. THE EFFECT OF ESTROGENIC ALFALFA CONSUMPTION IN CYCLIC EWES: THE PLASMA GONADOTROPIN PROFILE THROUGHOUT THE ESTROUS CYCLE by J. ALAN L. HETTLE Sc. (Agr.), The University of British Columbia, 197 A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE in THE FACULTY OF GRADUATE STUDIES Department of Animal Science We accept this thesis as conforming to the required standard THE UNIVERSITY OF BRITISH COLUMBIA September 1980 © J. Alan L. Hettle, 1980 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the Head of my department or by his or her representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. J. Alan L. Hettle Department of Animal Science The University of British Columbia 2357 Main Mall Vancouver, British Columbia, Canada V6T 2A2 Date: OCT- 07 , l%0 ABSTRACT Phyto-estrogens are known to cause reproductive failures in the ewe by interacting with uterine estrogen receptors. Further studies have demonstrated anomalous ovarian steroid levels which implicate the hypothalamus and pituitary. Estrogen receptors which bind phyto-estrogens have been recently demonstrated in ovine hypothalamic and pituitary tissues. It would then seem logical to assume that estrogen interactions in these tissues will be altered and result in abnormal gonadotropic synthesis or secretion.
    [Show full text]